• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Multidisciplinary treatment for small cell lung cancer].

作者信息

Saijo N, Eguchi K, Shimizu E, Shinkai T, Tominaga K, Takahashi K, Sasaki Y, Seki S

出版信息

Gan To Kagaku Ryoho. 1984 Mar;11(3):474-9.

PMID:6322700
Abstract

The effect of multidisciplinary treatment of small cell carcinoma of the lung was tested. The response rates to induction chemotherapy were 69.2% (9/13) and 57.1% (12/22) in small cell carcinoma of the lung with limited and extensive disease, respectively. The response rates of oat and intermediate cells were 63.6% (14/22) and 50% (5/10), respectively. Radiation therapy to primary site and mediastinum after induction chemotherapy was also effective, producing the response rates of 87.8% (7/8) and 58.3% (7/12) in limited disease and extensive disease, respectively. The non-responder and recurrent cases responded to chemotherapy with epipodophyllotoxin and/or cisplatin but not with mitomycin C and/or adriamycin. The median survival of all 37 cases was 12.2+ months, and those with limited and extensive cases were 14.8+ and 8.7 months, respectively.

摘要

相似文献

1
[Multidisciplinary treatment for small cell lung cancer].
Gan To Kagaku Ryoho. 1984 Mar;11(3):474-9.
2
[Pilot study of multi-cyclic combination chemotherapy in small cell lung cancer].小细胞肺癌多周期联合化疗的初步研究
Gan To Kagaku Ryoho. 1991 Mar;18(3):489-92.
3
Cyclic alternating chemotherapy for small cell carcinoma of the lung.小细胞肺癌的周期性交替化疗
Cancer Treat Rep. 1985 Nov;69(11):1241-2.
4
A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.环磷酰胺、阿霉素和长春新碱(CAV)/顺铂与依托泊苷(PVP)混合给药对比CAV-PVP序贯给药治疗小细胞肺癌患者的随机试验:长期随访结果
Cancer. 1998 Jul 15;83(2):283-90.
5
[Combination chemotherapy and radiotherapy in small cell carcinoma of the lung].[肺癌小细胞癌的联合化疗与放疗]
Gan To Kagaku Ryoho. 1986 Jul;13(7):2331-6.
6
[Chemotherapy of small cell lung cancer].[小细胞肺癌的化疗]
Gan To Kagaku Ryoho. 1996 Aug;23(9):1116-23.
7
[Benefits of cisplatin-based polychemotherapy in non-small cell bronchogenic carcinoma. Kyushu Lung Cancer Chemotherapy Study Group].[基于顺铂的多药化疗在非小细胞支气管肺癌中的益处。九州肺癌化疗研究组]
Gan To Kagaku Ryoho. 1988 Jun;15(6):1901-8.
8
Cisplatin and etoposide alternating with vincristine, doxorubicin and cyclophosphamide in patients with small cell lung cancer.
Eur J Respir Dis. 1985 Oct;67(4):294-300.
9
Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.小细胞肺癌的化疗:格林莱恩医院1993 - 1995年的经验
N Z Med J. 1998 Nov 27;111(1078):451-2, 453-4.
10
Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).复发性小细胞肺癌的二线化疗。顺铂和依托泊苷(EP方案)或环磷酰胺、表柔比星和长春新碱(CEV方案)一线治疗后交叉方案的结果。
Lung Cancer. 2005 May;48(2):251-61. doi: 10.1016/j.lungcan.2004.10.016. Epub 2004 Dec 15.